Market Research Blog – Page 11363 – New Product Development

Recordable Optical Disc Market Analysis, Size, Share, Growth, Trends & Forecast 2022-2029

The worldwide recordable optical plate market is scheduled to hold a total assets of US$ 2.5 Bn in 2022, yet is supposed to decline at a CAGR of – 3% over the gauge period (2022-2029) to arrive at an expected market valuation of US$ 2 Bn toward the finish of 2029.

The recordable optical circle market, which was esteemed at roughly US$ 2.5 Bn in 2022, is determined to see negativity later on years, according to the new report distributed by Future Market Insights (FMI)As per the report, Recordable Optical Disk Market is supposed to decline at a CAGR of – 3% over the conjecture period (2022-2029) to arrive at an expected market valuation of US$ 2 Bn toward the finish of 2029. as a general feeling of oldness poses a potential threat. The languor is in spite of the dependence on visual structures for capacity, as per FMI’s exploration.

As per the report, the development of noticeable media-administrations suppliers, for example, Spotify, Apple Music and TIDAL, began pulling on the ubiquity of recordable optical circle designs. Media specialist organizations revamped the guidelines of media utilization and the reception pace of these media web-based features developed huge amounts at a time.

Get a Sample Copy of Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-691

‘Manufacture-On-Demand’ DVDs and Blu-Ray Discs- Marking a New Milestone for Growth

As per the report, the trend of ‘manufactured-on-demand’ DVDs and blu-rays of popular TV shows and movies is favouring the market players. For instance, Amazon exclusively sells a series of ‘manufactured-on-demand’ DVDs and blu-rays of popular Nickelodeon shows and movies.

Moreover, popular media-services providers, such as Netflix, have also started bringing back popular TV series and movies in DVDs and blu-ray formats to treat their loyal subscribers, which in turn has resulted in a promising comeback for DVDs and Blu-ray discs.

The report opines that blu-ray disc will continue being the top-seller, with revenues estimated to approach US$ 2 Bn in 2022. Optimum storage capacities with ‘best-in-class’ features remain two of the key selling points of blu-ray discs. Sales of the recordable optical disc via online channels will continue to put offline channels in the shade.

Professional Use of Recordable Optical Disc to Show Positive Leaps,

As per the report, media houses continue to rely on recordable optical disc formats for local storage, followed by software and IT ecosystems. Key players in the recordable optical disc market are focusing on incremental innovations that would further help them boost their sustenance in the market.

Apart from product features, brands are also focusing on nourishing the longevity of their recordable optical disc offerings via reflective layers. In addition, strategic partnerships seem the best way forward for the brands to sustain with considerable revenue growth, states the research study.

Feel free to Ask your Queries @
https://www.futuremarketinsights.com/ask-question/rep-gb-691

COVID-19 Crisis Evaluation

The COVID-19 pandemic worsened the already in-bad-shape recordable optical disc industry. The manufacturing sector was majorly impacted by pandemic restrictions across the world. In the first quarter of 2020, as coronavirus infections spread, the world went into a lockdown situation and disrupted market activities on a global scale.

As factories all over the world were shut, it hindered the production and manufacturing of recordable optical discs. The market for recordable optical discs was already experiencing a downfall, and this pandemic made the situation worse.

However, optical discs are still vital in many professional operations where the reliability of these discs has been proven time and again. This factor alone is expected to somewhat slow down the decline in demand for recordable optical discs in the post-pandemic era.

Competitive Landscape

Recordable optical disc manufacturers are struggling to make sales due to increase in popularity of advanced storage technologies that are being widely adopted. However, recordable optical disc suppliers are now focusing on data security and secure data storage for enterprise use and are trying to boost their sales revenue via commercial channels of application.

In July 2021, Apple TV+, a subscription-based streaming service, announced the launch of its first physical media disc release. The title ‘Defending Jacob’ a limited series was released on DVD storage media and Blu-ray. More titles are expected to be released on physical discs from Apple TV+ streaming service.
In June 2020, Sony a leading electronics manufacturer announced the launch of a new optical disc capable of storing data for 100 years. The new disk is capable of reading at a rate of 3 Gbps and writing at a rate of 1.5 Gbps.

Before Buying, Visit for Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-691

Key Segments of Recordable Optical Disc Industry Survey

Recordable Optical Disc Market by Product Type:

Compact Discs (CD)
Digital Versatile Discs (DVD)
Blu-ray Disc

Recordable Optical Disc Market by Sales Channel:

Online Sales of Recordable Optical Discs
Offline Sales of Recordable Optical Discs
Sales of Recordable Optical Discs by Distributors
Sales of Recordable Optical Discs by Resellers
Direct Sales of Sales of Recordable Optical Discs

Recordable Optical Disc Market by End Use:

Recordable Optical Discs for Consumers
Recordable Optical Discs for Professionals

About Us

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 7-years.

Contact:

Future Market Insights Inc.  
Christiana Corporate,
200 Continental Drive,
Suite 401, Newark,
Delaware – 19713, USA  
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Smart Elevator Automation System Market Analysis, Driver, Trends, Business Overview, Key Value, Demand & Forecast by 2027

As far as worth, the worldwide smart elevator automation system market is supposed to develop at a CAGR of 14.3% during the estimate time frame. The worldwide smart elevator automation system market was esteemed at US$ 8,487.6 Mn in 2016, and is projected to develop essentially to arrive at US$ 36,417.8 Mn by 2027 attributable to expanding development of new tall structures and developing urbanization.

In this report, FMI has divided the worldwide smart elevator automation system market based on help, part, end clients and area. By administration, the smart elevator automation system market is additionally portioned into establishment administration, fix and upkeep administration and modernization administration.

Request a Sample of this Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-469

Future Market Insights as of late distributed a report named “Smart Elevator Automation System Market – Global Industry Analysis 2012 – 2016 and Opportunity Assessment 2017 – 2027”. Smart elevator automation system is another age of elevators furnished with imaginative innovations, which offer different offices alongside security.

The smart elevator automation system is intended to limit the general energy utilization and oversee traveler traffic productively inside a structure. With the progression in innovation and changing structure foundation, smart elevator automation systems have become adaptable to oversee building traffic safely. These variables are supposed to support the development of the worldwide smart elevator automation system market.

Smart Elevator Automation System Market: Segmental & Regional Forecast

Governmental regulations & standards for global green infrastructure, reduction in the operational cost and automation are the major factors expected to drive the growth of the smart elevator automation system market. In terms of value, the residential sector sub-segment is projected to register high growth during the forecast period in the global smart elevator automation system market.

Based on component, the card reader sub-segment in the smart elevator automation system market is expected to grow at a high CAGR of 19.2% over the forecast period. However, the sensor motor & automation system sub-segment is expected to capture large share in the global smart elevator automation system market as their demand is increasing to maximise energy efficiency and elevator travel speed.

Ask An Analyst @
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-469

Furthermore, the global smart elevator automation system market has been segmented into seven major regions, namely North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). In terms of value, the Asia Pacific Exc. Japan Smart elevator automation system market is estimated to expand with a CAGR of 18.6% over the forecast period.

This can be attributed to transformation of the existing infrastructure and increasing number of smart city projects. In Western Europe, Germany is expected to be the dominant market for smart elevator automation system, and to create incremental opportunity of US$ 2,042.8 Mn between 2017 and 2027.The growing demand for enhanced safety and security systems is one of the major factors fuelling the growth of the smart elevator automation system market in Western Europe.

Companies Operating in the Smart Elevator Automation System Market

Examples of some of the key participants covered in the report of the smart elevator automation system market include Fujitec, Mitsubishi, Hitachi, Kone Corporation, Otis Elevator, Schindler, ThyssenKrupp Elevator, Tyco International, and Honeywell. The report also describes company-specific strategies, key differentiators, market structure and competitive share analysis related to prominent industry stakeholders.

Key Segments Covered

By Service
By Component
By End-user

Key Regions covered:

North America
Latin America
Western Europe
Eastern Europe
Japan
APEJ (Asia Pacific excluding Japan)
MEA

About Us

Contact:

Digital Transformation in Healthcare Market : Key Players, Applications, Outlook, SWOT Analysis & Forecast to 2031

Expanded and computer generated reality are innovative arrangements that are revolutionizing the healthcare industry. From 2018 to 2023, the worth of the healthcare-based AR and VR industry is supposed to dramatically develop. Accordingly, there are huge undiscovered learning experiences for the digital transformation in healthcare market.

The healthcare industry continues to develop, from the reception of telemedicine to the utilization of mechanical interaction computerization (RPA) to work on quiet information. Another review from Future Market Insights (FMI) shows that the approach of innovative innovations will empower patients to get further developed care with the assistance of computer generated reality, wearable gadgets and different advances. These advances are supposed to drive digital transformation in healthcare.

Among the different end-clients, clinics and clinics are supposed to hold a leading offer in the digital transformation of the healthcare market owing to the growing reception of IoT that guarantees better network in the healthcare industry.

Request Sample of This Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-708

Key Implications: Digital Transformation of Healthcare Market

Global Digital Transformation of Healthcare Market is projected to register a CAGR of over 14% during the forecast period 2021-2031
Presence of sophisticated healthcare infrastructure supports US expansion, accounting for more than 80% of total North American demand
Investments in smart healthcare will boost year-over-year growth in the UK to 14.4% in 2021.
Exponential growth will be possible in Germany and France, particularly due to increased spending on expanding healthcare.
China is expected to remain the market leading the digital transformation of healthcare in East Asia, while Japan is expected to grow at a faster pace.

The impact of COVID-19 on the digital transformation of the healthcare market

COVID-19 is disrupting businesses, industries and somewhat disproportionate health care across the country. This serious situation has led to a massive digital transformation of the healthcare industry, reducing operating costs, saving treatment time and ultimately improving healthcare quality. Medical advancement is considered a step-by-step evolution, and pandemics have accelerated change and have seen pioneering research in the medical sciences.

For example, telemedicine software (or remote patient monitoring) became the norm in 2020, eliminating the need for physical human interaction. This has become the most important advantage during the COVID-19 crisis. Telemedicine software has also provided healthcare professionals with greater geographic coverage, especially when healthcare resources are limited.

Accordingly, the digital transformation of the healthcare market is expected to grow 10-12% from the previous year from 2019 to 2021.

Rapid adoption of mobility services and healthcare mobile apps has become a major trend

Healthcare organizations are increasingly paying attention to mobile-based communications and encouraging employees to bring their own devices for work-related purposes, which in turn reduces the costs associated with purchasing medical communications devices. This is expected to increase the demand for mobility services. Medical mobility services also allow healthcare organizations to access patient data from anywhere and share insights with patients in real time.

Healthcare organizations around the world are focused on providing personalized healthcare apps for wearable fitness and medical devices. These applications allow patients to access medical information through mobile and devices. This, in turn, is expected to fuel market growth in the near future.

Who is the winner?

Companies operating in the market are currently focused on adopting advanced technologies. With the intention of making healthcare smarter, digital transformation will continue to accelerate within the healthcare sector. Major companies operating in the market include IBM Corporation, CGI Group Inc., Accenture PLC, Deloitte LLP, and HCL Technologies.

Ask Analyst @
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-708

Key Segments Covered

Solution

Software
- Electronic Health Record (EHR) Software
- Connected Medical Billing
- Healthcare Information System (HIS)
- Healthcare CRM Software
- Healthcare ERP Software
Service
- Digital Transformation Consulting
- Digital Transformation Technology Implementation & Integration

End User

Hospitals & Clinics
Pharma Companies
Life Science & Biotech Companies
Healthcare Insurance Providers
Others

Region

North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa (MEA)

About Us

Contact:

Smart Fitness Market Growth, SWOT Analysis, Top Companies, Competitor Landscape, Regional Outlook 2031

The worldwide smart fitness market income added up to ~US$ 13 Bn in 2020, as per Future Market Insights (FMI). The general smart fitness market size is supposed to arrive at ~US$ 50 Bn by 2031, developing at a CAGR of 12% for 2021 – 31.

As per the smart fitness industry examination by Future Market Insights (FMI), the interest enrolled in the market will increment at a sound CAGR of 12% from 2021-2031.

The report likewise estimates that the market will outperform a valuation of ~US$ 15 Bn toward the finish of 2021. According to FMI, advancements in wearable detecting innovations and send off of pocket-accommodating wearable fitness trackers for wellbeing checking and tending to medical problems will stay boss development drivers.

Get a Sample Copy of Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-36

In the beyond couple of years, the rising ubiquity of wearable fitness trackers has urged producers to zero in on fostering the new plans and examples in type of groups and looks as well as looking like rings, pendants, and identifications that can be effectively conveyed or connected to attire.

Key Takeaways: Smart Fitness Market

By component, the smart accessories segment is anticipated to account for the leading share in the global demand for smart fitness. The segment is estimated to grow at a robust CAGR through 2031.
The adoption of smart accessories like smart watches is expected to rise at maximum pace. As per FMI, demand in this segment will increase by a 2X between 2021 and 2031.
North America is expected to lead the market followed by Europe in 2021.
South Asia & Pacific is anticipated to emerge as the fastest growing region between 2021 & 2031.
The market in U.K. is expected to progress at a CAGR of around 15% through 2031.
In the India, sales are expected to increase at a CAGR of nearly 18% over the next ten years.

Demand for Wearable Devices is Bolstering the Market Growth

The demand for wearable devices such as smart bands, smart watches, activity trackers integrated with AI capabilities is increasing as these devices help in detecting irregularities in health data and give early warnings for condition like heart disease or diabetes. AI-enabled wearable devices are gaining traction as they help in monitoring the health and give alerts about movements, incorrect posture, and other vital health factors.

Wearable device provides fitness, sleep, and recovery data to help an individual adopt a healthy lifestyle. Many smart watch vendors are adding blood oxygen sensors in their device as standard, ECG monitors, and other functionalities to provide warnings or early signs of potential ailment and make suggestions about improvement in health.

Demand for Wearable Devices is Bolstering the Market Growth

Ask for Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-36

More Valuable Insights on Smart Fitness Market

FMI’s report on the smart fitness industry research is segmented into three major sections – component (smart accessories, strength training equipment, cardiovascular equipment, cross-training equipment), smart accessories (smart watches, smart bands, activity trackers, heart rate, monitor, pedometer, sleep quality monitor), and region (North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East & Africa), to help readers understand and evaluate lucrative opportunities in the smart fitness demand outlook.

Smart Fitness Outlook by Category

By Component:

Smart Accessories
Strength Training Equipment
Cardiovascular Equipment
Cross-training Equipment

By Smart Accessories:

Smart Watches
Smart Bands
Activity Trackers
Heart Monitor
Pedometer
Sleep Quality Monitor

By Region:

North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East & Africa

About Us

Contact:

CNS treatment and therapy market is predicted to grow at a moderate CAGR of 4.8% during the forecast period 2022-2032

In 2020, the global market for central nervous system treatments was valued at USD 81.67 billion. The CNS treatment and therapy market  is estimated to increase at a CAGR of 4.8% during the forecast period, from US$ 112 billion in 2021 to US$ 192 billion by 2032. 

COVID-19 has had an unusual and devastating worldwide impact, with central nervous system treatment experiencing a negative demand shock across all regions during the pandemic.

According to the market study by FMI, the CNS treatment and therapy market is expected to shrink by -4.2 per cent in 2020. When the pandemic is finished, this market’s demand and growth are foreseen to revert to pre-pandemic levels, resulting in a sharp increase in CAGR.

The rising frequency of neurological illnesses, as well as the rising rates of diagnosis in both industrialized and developing countries, has resulted in a vast patient pool requiring system treatment.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14431

This is bolstered by non-profit groups, healthcare institutions, and market players’ efforts to raise awareness about these disorders through campaigns and other means. These characteristics, combined with the release of new generations of antipsychotic medications by global and domestic competitors, are expected to fuel the nervous system market‘s growth possibilities over the forecast period.

Over the forecast period, potential product introductions for treating neurological illnesses are expected to drive CNS treatment and therapy market expansion. The availability of treatment in developing nations is likely to grow as a result of these planned launches.

The nervous system treatment market growth is restricted by a time-consuming approval process and a strict regulatory framework. The cost of therapeutic research and development is higher than in other therapeutic illness areas. Owing to the medications targeting the central nervous system must cross blood-brain barriers, they must go through a lengthy development and approval process. 

Patient recruiting is likewise a hurdle for the business, as is the overall pharmaceutical industry’s cost per approval. Furthermore, adverse events associated with the usage of these pharmaceuticals are expected to stymie the global CNS therapeutics market‘s expansion.

Within the pharmaceutical sector, R&D is a complex process and a critical decision. It entails a thorough investigation of the safety and efficacy of new pharmaceuticals, as well as compliance with regulatory requirements before they are released onto the nervous system treatment market.

R&D spending may not necessarily result in increased profits, making it a hazardous investment.

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-14431

As a result, drug prices are raised to recoup the costs. The high-risk R&D investment for CNS therapeutics medication development may deter pharmaceutical corporations from investing in CNS therapies.

Additionally, unfavourable reactions to certain CNS medications, such as antiepileptic treatments, may stifle overall market growth.

Key Takeaways

North America dominated the CNS treatment and therapy market for central nervous system therapeutics in 2020, accounting for 47.3 per cent of total revenue.
Over the next eight years, the market for central nervous system therapeutics in the Asia Pacific is predicted to develop at the fastest rate. During the projection period, improving healthcare infrastructure in emerging economies like India and China, as well as a large patient pool with significant unmet medical requirements, are expected to drive treatment adoption rates.
In the year 2020, the non-biologics sector dominated the global CNS treatment and therapy market. The regulatory body imposes fewer regulations on pharmaceuticals than on biologics for approval, which explains their dominance.
Immunomodulators accounted for the majority of the market in 2020. The ongoing invention and development of pharmaceutical compounds to treat disease indications is a primary factor driving immunomodulators in the market.

Competitive Landscape

Owing to multiple businesses focusing on central nervous system therapies, the industry is fragmented. Companies have been able to maintain a solid position in the CNS treatment and therapy market because of a robust pipeline and strategic distribution arrangements.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14431

Biogen is the CNS treatment and therapy market leader, with the company’s key compounds expected to generate significant revenue by 2020. Johnson & Johnson Services, Inc., Pfizer Inc., RF. Hoffman-La Roche Ltd., Novartis AG, Sanofi, Teva Pharmaceutical Industries, and Otsuka Holdings are among the market’s other participants.

About FMI:

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Viral Vector Development Market is estimated to grow at a robust CAGR of 18.2% during forecast period by 2032

Despite the COVID-19 dilemma, the global Viral Vector Development Market, which was forecast to be worth US$ 534 million in 2021, is expected to increase to US$3.2 billion by 2032, at a CAGR of 18.2% through 2032.

The increased prevalence of target diseases and disorders, the accessibility of funding for therapeutic gene strategies, the efficacy of viral vectors in gene therapy delivery, and continuous research into viral vector-based gene and cell therapies are some of the important drivers driving the growing vector manufacturing expansion.

Emerging markets’ untapped potential for the demand for viral vector development is likely to provide profitable growth prospects for market participants.

Government measures such as direct support for viral vector manufacturing are raising awareness, while the regulatory environment is becoming more simplified through innovations such as faster clearance processes propelling the viral vector development market forward.

The market for vector manufacturing is predicted to increase in the future as a result of the aforementioned causes. The high cost of gene therapies and limitations in viral vector production capacity, on the other hand, may have a negative impact on market growth.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14415

The viral vector development market is divided into cancer, genetic disorders, infectious diseases, and other diseases based on disease. The expanding study on viral vectors gene treatments for cancer can be attributable to its high proportion.

The viral vector manufacturing market is divided into two applications–gene therapy and vaccinology. During the projected period, the gene therapy segment is expected to increase at the fastest rate. In the following years, new vectors and applications for gene therapy are expected to be researched, as well as new drugs found.

Furthermore, the use of cutting-edge technologies such as MP-Seq might help accelerate the development of viral vectors. Some barriers may obstruct the vector manufacturing market, such as tight government rules that cause product approval to be delayed.

Some regulatory criteria, such as crucial raw material control, must be followed when manufacturing viral vectors. Few regulatory rules for the creation of viral vectors have been established by the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Japanese Pharmaceuticals & Medical Devices Agency (PMDA).

The global viral vector market is growing due to the rising prevalence of various genetic disorders and target diseases such as infectious diseases, increased funding availability for gene therapy development, research efforts in the field of viral vector-based cell and gene therapies, and increasing efficacy of viral vectors in delivering gene therapy.

The viral vectors market is developing due to rising investments in biopharmaceutical manufacturing, rising health spending, technological improvements, and the healthcare demands of an aging population. The viral vector development market is also anticipated to grow due to an increase in the number of clinical investigations and prospective uses in innovative medication delivery systems.

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-14415

Key Takeaways

Retroviral Vectors, one of the report’s sectors, is expected to grow at an 18.5 percent compound annual growth rate (CAGR) and reach US$547.1 million by the conclusion of the analysis period.
After a detailed examination of the pandemic’s commercial ramifications and the resulting economic crisis, the Adenoviral Vectors segment’s growth is revised to an 18.8% CAGR for the next seven years.
In the year 2021, the viral vector manufacturing market in the United States is expected to be worth $327.6 million.
China, the world’s second-largest economy, is expected to reach a viral vector development market size of US$49 million by 2026, representing a 21.9 percent CAGR throughout the study period.
Japan and Canada are two other important geographic markets, with forecasted growth rates of 15.8 percent and 16 percent, respectively, for the analysis period. Germany is expected to expand at a CAGR of around 15.1 percent in Europe.

Competitive Landscape

The sales of viral vector manufacturing are moderately competitive, with many major competitors. Due to the increased demand for novel therapies to treat life-threatening diseases like cancer, a number of smaller businesses are entering the market and gaining a large share of the industry.

Among the major players in the market are Kaneka Corporation, Cognate BioServices Inc., Finvector, AstraZeneca, Merck KGaA, Uniqure NV, Oxford BioMedica PLC, Johnson & Johnson (Janssen Global Services, LLC), Vibalogics, Fujifilm Holdings Corporation.

Recent Developments

Merck plans to expand its global contract development and manufacturing organisation (CDMO) footprint by opening a new viral vector contract development manufacturing facility for gene therapy in Carlsbad, California, in October 2021.
LEXEO Therapeutics and FUJIFILM Diosynth Biotechnologies formed a strategic partnership in October 2021 to support the research and manufacturing of LEXEO’s AAV-mediated gene treatments.
Fujifilm Corporation announced intentions to invest USD 40 million in establishing a new production plant for viral vector manufacture and related research in January 2021.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14415

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Key Segments

By Vector Type:

Retro-viral Vectors
Adeno-viral Vectors
Adeno-associated Viral Vectors
Others

By Disease:

Genetic Disorders
Infectious Diseases
Others

By End Use:

Pharma & Biopharma Companies
Research Institutes
Others

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)

About FMI:

Contact:

Oncology Nutrition Market growing at a CAGR of 8.9% over the analysis period 2022-2032

Amid the COVID-19 crisis, the global market for Oncology Nutrition estimated at US$1.1 Billion in the year 2021, is projected to reach a revised size of US$3.14 Billion by 2027, growing at a CAGR of 8.9% over the analysis period.

Malnutrition triggered by cancer treatment is the most common side-effect among cancer patients. Specifically, malnutrition is more prevalent among individuals with digestive cancers or head and neck cancers.

Head & Neck Cancer, one of the segments analyzed in the report, is projected to grow at a 7.8% CAGR to reach US$472.2 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Stomach & Gastrointestinal segment is readjusted to a revised 10.9% CAGR for the next 7-year period. This segment currently accounts for a 22.9% share of the global Oncology Nutrition market.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14411

Continuously increasing number of cancer patients is posing serious healthcare challenges for various countries. Several healthcare professionals consider inappropriate diet as well as inactive lifestyle for approximately 85% of global cancer cases. On the other hand, obesity and food attributes for 35% as well as 30% of all cancer related deaths, respectively.

Consuming large quantities of nutritious food significantly improve stamina and strength of patients undergoing cancer treatment. Owing to their abilities to prevent growth of cancer cells, demand for nutritional food is witnessing an upward momentum. Propelled by rising popularity of homecare nutritional products, the global market for oncology nutrition is exhibiting robust growth.

In order to tap the available opportunity, companies are devising a broad range of innovative strategies. Hospitals, retail pharmacies, and online pharmacies are some of the major end-users of oncology nutrition segment. Hospitals currently account for majority of share in the global oncology nutrition market, due to constantly increasing number of cancer patients. In order to ensure timely treatment, various leading global healthcare providers are now constructing high-end cancer diagnosis and care centers.

The U.S. Market is Estimated at $412.6 Million in 2021, While China is Forecast to Reach $165 Million by 2026

The Oncology Nutrition market in the U.S. is estimated at US$412.6 Million in the year 2021. The country currently accounts for a 35.62% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$165 Million by the year 2026 trailing a CAGR of 10.6% through the analysis period.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.4% and 7.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR while Rest of European market (as defined in the study) will reach US$182.4 Million by the close of the analysis period.

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-14411

The entire market for oncology nutrition negates a highly important cancer nutrition element, which is the patient`s daily dietary regimen. Even though nutritional formulas and nutraceuticals are great items for selling with their respective beneficial impacts on a patient`s nutritional status, only a handful of such producers and marketers are actually interested in educating patients on a healthy diet`s importance in the long-run. Nevertheless, suppliers are already providing those items needed for short-term gain and patients too, prefer quick fixes.

Key Players

FMC Corporation
Danone India
Abbott
Aceto
B. Braun Melsungen AG
Baxter
Fresenius Kabi AG
Global Health Products, Inc.
Hormel Foods Corporation
Mead Johnson & Company, LLC
Meiji Holdings Co., Ltd
Nestlé S.A.
BioSig Technologies, Inc.
Auris Health, Inc.

KEY SEGMENTS

By Cancer Type

Head & Neck Cancer
Stomach & Gastrointestinal Cancers
Blood Cancer
Breast Cancer
Lung Cancer
Other cancers

By End Use:

Hospitals
Home Care
Others

By Geography:

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe (RoE)
Asia Pacific
Latin America
Middle East and Africa

About FMI:

Contact:

Mortuary Bag Market is exhibiting a CAGR of 4.83% in the forecast period 2022 to 2032

The mortuary bags market was worth US$ 375.64 Mn in 2021 and is predicted to increase at a CAGR of 4.83% in the next years to US$ 498.62 Mn by 2027.

The increased incidence of diseases and pandemics, as well as an increase in the number of traffic accidents, are some of the primary causes driving up demand for mortuary bags. The number of people killed in car accidents has risen in recent years.

Pandemics and epidemics are expected to become more often in the future, boosting mortuary bags market development. Virus-related fatalities necessitate the use of high-grade mortuary bags. Even after an infected individual dies, the virus can spread. The emergence of diseases and pandemics such as COVID-19, Ebola, MERS-CoV, and avian flu in recent years has raised demand for mortuary bags across the world.

Furthermore, the rising prevalence of several non-communicable disorders is expected to increase the mortuary bags market throughout the forecast period.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14402

Over the projected period, Polyvinyl Chloride (PVC) the raw material sector of mortuary bags market is expected to increase at the quickest rate. PVC is a cost-effective synthetic material that ranks third in popularity. It’s utilised to make mortuary bags because it efficiently prevents bodily fluid leaking. Mortuary bags are also used to wrap the bodies of people who have died as a result of infectious illnesses.

Polyethylene is a lightweight, long-lasting, low-cost material that is used all over the world in the mortuary bags market. Polyethylene is primarily utilised in the production of mortuary bags, which are used to wrap and transport the bodies of non-communicable illness patients.

Due to the increasing frequency of cardiovascular disorders, the hospital segment of mortuary bags market is expected to increase at the quickest rate throughout the projection period.

Over the projected period, a rising number of individuals suffering from various types of cardiac illnesses and disorders are expected to support mortuary bags market growth.

Over the projection period, demand for heavy duty and bariatric bags is expected to increase significantly. The rising incidence of obesity throughout the world is responsible for the segment’s rise in mortuary bags market.

Refrigerators are used in morgues rooms to slow the decomposition of deceased bodies held for autopsy or research. Human bodies are wrapped in mortuary bags and preserved in freezers in the morgue. Furthermore, deaths from traffic accidents and criminal activity have grown in recent years, and the bodies are sent to the morgue for further examination.

The increased frequency of the COVID-19 pandemic and the region’s expanding obese population are driving the mortuary bags market in North America.

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-14402

Over the projected period, the mortuary bags market in Asia Pacific is expected to develop at the quickest rate. The rising incidence of diabetes and the growing elderly population in the area are driving the mortuary bags market’s expansion.

Adults in India have an 8.9% prevalence incidence of diabetes. The high incidence of diabetes in the area is projected to support the mortuary bags market’s growth.

KEY TAKEAWAYS:

The polyethylene category led the mortuary bags market, accounting for roughly 31.0% of total sales.
Owing to the increased frequency of cardiovascular illnesses and the increasing occurrence of epidemics and pandemics, the adult bags segment dominated the mortuary bags market and had the biggest revenue share of 45.5%.
The hospitals’ segment accounted for a share of 44.03% in the mortuary bags market.
The mortuary bags market was led by the morgue sector, which accounted for 44.4% of total revenue.
The mortuary bags market was dominated by North America, which accounted for 15.9% of total sales.
Over the projection period for mortuary bags market, North America is predicted to increase at a CAGR of 5.7%

COMPETITIVE LANDSCAPE:

Some of the key players operating in the mortuary bags market include Desco Medical India, Suzhou Thriving Medical Equipment Corp., Changzhou Precise Package Ltd, Dongguan Bright Sea Industrial Co, Ltd., Shen Zhen Flowkin Tech Co, Ltd, Heaven Healthcare Ltd, Debdarm Enterprises, Track Manufacturing Co, Private Limited, Plastic Fabric Solution Inc, Associated Bag, Busse Hospital Disposables, Extra Packaging Corp, Peerless Plastics Mortuary, and Deimos Zip Harness.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14402

Mortuary bags market players are focusing on pursuing inorganic growth strategies such as acquisitions and strategic partnerships to expand their presence, enhance product portfolio, and improve expertise in the mortuary bags market.

Key Market Segments

By Material type:

PVC
Polyethylene
Nylon
Polyester
Other Material types

By End-Use:

Hospitals
Mortuary
Other End-Users

About FMI:

Contact:

Human Growth Hormone Treatment & Drugs Market is Projected to Achieve US$ 4.8 Billion by 2032

The human growth hormone treatment & drugs market was valued at US$ 3.4 billion in 2021, and it is predicted to expand to US$ 4.8 billion by 2032, with a compound annual growth rate (CAGR) of 3.3% from 2022 to 2032.

Industry participants’ investments, the presence of a solid pipeline, extensive R&D efforts, a comprehensive product portfolio, and expanding government initiatives are all projected to drive the demand for human growth hormone treatment & drugs.

The global human growth hormone treatment & drugs market share is expected to be impacted by the COVID-19 epidemic. Patients with low growth hormone secretion are at risk for COVID-19, which necessitates immediate intervention to aid in COVID-19 prevention.

Patients with Prader-Willi syndrome, on the other hand, must exercise caution in order to reduce their risk of contracting COVID-19. Furthermore, people with Prader-Willi syndrome may not exhibit typical symptoms such as a high fever or a higher-than-normal pain threshold, delaying the diagnosis of COVID-19.

Turner syndrome patients are at an increased risk of contracting the COVID-19 virus, which can cause serious disease.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14401

Human growth hormone manufacturers are investing in research and development to create a growth hormone with fewer side effects and the potential to be a long-term treatment.

The human growth hormone supplements market is growing due to an increase in disorders connected to growth hormone insufficiency, an increase in the use of ageing hormones, government and private sector efforts to raise awareness of growth hormone deficit, and high productivity.

Other reasons such as greater understanding of the treatment process, an increase in the number of health conditions, and an increase in the number of neuropsychiatric cases are expected to boost the human growth hormone treatment & drugs market size’s growth. Human growth hormone supplements market expansion is projected to be driven by the quick growth of new human growth hormone novels.

As per the global human growth hormone treatment & drugs market study, the industry is likely to be driven by initiatives taken by various government and private organizations to raise awareness about GH deficiency and human growth hormone treatment.

International Children’s Growth Awareness Day is observed every year by the International Coalition of Organizations Supporting Endocrine Patients (ICOSEP), a nonprofit charitable organization based in the United States, to increase public knowledge regarding the early detection and intervention of human growth hormone problems, particularly in children.

However, the high price of hGH therapies, as well as severe hGH-related side effects, may negatively impact the human growth hormone for sale over the projection period.

Knee, hip, or other joint discomforts; allergic reactions, such as redness, swelling, or hives; and an increase in blood sugar levels are all possible adverse effects of GH hormone therapy, according to UPMC Children’s Hospital of Pittsburgh.

Ask An expert here @ https://www.futuremarketinsights.com/askus/rep-gb-14401

Key Takeaways

In 2021, the US human growth hormone treatment & drugs market was expected to be worth $1.3 billion, while China’s market is expected to be worth $285.1 million by 2026.
In 2020, the Turner syndrome category accounted for a significant portion of the human growth hormone supplements market, and this trend is likely to continue during the forecast period.
Led by countries such as Australia, India, and South Korea, the Intravenous segment market in Asia-Pacific is forecast to reach US$14.4 Million by the year 2026.
Subcutaneous, one of the report’s segments, is expected to rise at a 4 per cent compound annual growth rate (CAGR) to reach US$2.7 billion by the conclusion of the analysis period.

“A healthy product portfolio and extensive Market research investments for the emergence of future growth hormone treatments are projected to propel the sales of human growth hormone treatment & drugs.”

Competitive Landscape

The demand for human growth hormone treatment & drugs is moderately concentrated, with a few key manufacturers owning a large portion of the industry. Furthermore, several active collaborations are underway to generate more effective and long-acting subtypes of human growth hormones.

Key human growth hormone manufacturers include Eli Lilly and Company, Ipsen S.A., EMD Serono Inc., Novo Nordisk A/S, Genentech, Inc (Roche), AnkeBio Co. Ltd, GeneScience Pharmaceuticals Co. Ltd, LG Life Sciences and Ferring Pharmaceuticals.

Pfizer Inc. began a Phase III research trial in February 2021 to assess the efficacy and security of somatropin in a group of Japanese patients with Prader-Willi Syndrome (PWS).

In October 2020, Erasmus Medical Center, in collaboration with Pfizer, the Foundation for Prader-Willi Research, and the Prader-Willi Fonds, launched a Phase III clinical trial to evaluate the impact of growth hormone treatment (Genotropin) on physical and psychosocial wellbeing in adults with Prader-Willi syndrome who are 30 years or older.

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-14401

Key Segments

By Route of Administration:

Subcutaneous
Intramuscular
Intravenous
Oral

By Application:

Growth Hormone Deficiency
Turner Syndrome
Idiopatich Short Stature (ISS)
Prader-Willi Syndrome (PWS)
Other Applications

By Distribution Channel:

Hospital Pharmacy
Speciality Pharmacy
Retail Pharmacy
Online Pharmacy

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)

About FMI:

Contact:

Sleep Apnea Devices Market is projected to register a CAGR of 7.8% during the forecast period by 2032

The expanding prevalence of sleep apnea and related co-morbidities and expanding knowledge about sleep disorders are among the primary drivers driving overall sleep apnea devices market expansion.

Technological improvement is expected to boost the sleep apnea devices market growth during the forecast period. These improvements in oral appliances, oxygen devices, and actigraphy systems have improved sleep disorders’ treatment results and success rate.

Players in the sleep apnea devices market are concentrating their efforts on research and development in order to create novel technology.

Newly released lightweight, portable sleep apnea solutions are integrated with pressure compensating sensors that can correct for altitude-related reductions in atmospheric pressure, enhancing their acceptance. Sleep apnea devices are becoming increasingly popular since they provide patients with more options and freedom.

Thus, the adoption of technology-enabled sleep apnea devices for both diagnostic and therapeutic reasons in various sleep disorders is expected to skyrocket in the future years.

One of the key challenges impeding the adoption of sleep apnea devices is a lack of commitment to sleep apnea therapy. Positive airway pressure sleep apnea devices are highly recommended for treating a variety of sleep disorders. Despite their great effectiveness, these devices’ action efficacy is limited in certain circumstances due to the fact that they require correct and frequent usage as well as ongoing medical monitoring.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14383

In the medium term, this lack of adherence will be a key impediment to the expansion of the sleep apnea equipment market. However, in the long run, it will have little influence because sleep apnea devices manufacturers are focusing on making their sleep apnea devices more technologically sophisticated and lowering the difficulties associated with their adherence to sleep apnea therapy.

The increased incidence of sleep disorders and related co-morbidities is predicted to considerably enhance sleep apnea devices market revenue.

The rapidly rising senior population suffering from sleep apnea and related health concerns have accelerated the need for sleep disorders diagnosis and treatment, which has favourably impacted the sleep apnea devices market revenue.

Key Takeaways:

By type, therapeutic devices account for the majority of the market for sleep apnea devices owing to the increasing adoption of sleep apnea therapeutic devices and improving reimbursement scenarios for these devices.
By end use, the home care settings segment is expected to grow at the fastest CAGR due to increasing patient and insurance company preference for home sleep testing, as well as a favourable reimbursement scenario for home sleep testing.
Due to the rising prevalence of elderly people with chronic diseases such as diabetes and obesity, the geriatric segment is expected to dominate the sleep apnea devices market, thereby spiking the sales of sleep apnea devices.
The direct tender segment is expected to dominate the global sleep apnea devices market since it provides high-quality and easily accessible sleep apnea devices to hospitals, diagnostic centers, ambulatory care centers, and specialty care centers.
During the forecast period, Asia Pacific is expected to advance at a rapid pace and experience huge demand for sleep apnea devices on account rising elderly population and an increase in the prevalence of lifestyle illnesses.

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-14383

“North America is projected to be at the forefront of the sleep apnea devices market due to the prevalence of expanding technological advancement in the region and major market players. On account of rising healthcare costs and well-established healthcare infrastructure, the obstructive sleep apnea syndrome segment in the United States of North America is expected to hold a large sleep apnea devices market share.” says an FMI analyst.

Competitive Landscape:

The major sleep apnea devices market companies providing sleep apnea devices are ResMed, Itamar Medical Ltd., Natus Medical Incorporated, CONTEC MEDICAL SYSTEMS CO., LTD, Koninklijke Philips N.V., BMC Medical Co., Ltd., SomnoMed, Medicom MTD Ltd, Somnowell, Fisher & Paykel Healthcare Limited Compumedics Limited.

Many product launches and agreements are also being initiated by companies around the world, which is accelerating the sleep apnea devices market opportunities.

By Key Players

BMC Medical Co., Ltd.
LivaNova PLC
Cadwell Laboratories Inc.
Fisher & Paykel Healthcare
Invacare Corporation
Itamar Medical Ltd
Natus Medical Inc.
Nihon Kohden
Koninklijke Philips N.V.
ResMed Inc.
Teleflex Inc.
Drive DeVilbiss International

About FMI:

Contact: